Xvivo Perfusion AB
XVIVO.ST
#5023
Rank
NZ$2.22 B
Marketcap
$70.67
Share price
0.00%
Change (1 day)
89.27%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): NZ$18.82 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are NZ$65.99 Million. In 2023 the company made an earning of NZ$15.76 Million, an increase over its 2022 earnings that were of NZ$3.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$18.82 M19.43%
2023 NZ$15.76 M309.49%
2022 NZ$3.84 M226.49%
2021 NZ$1.17 M-110.72%
2020 -NZ$11.01 Million-1221.07%
2019 NZ$0.98 M-70.61%
2018 NZ$3.33 M117.32%
2017 NZ$1.53 M146.09%
2016 NZ$0.62 M-61.52%
2015 NZ$1.62 M-3.88%
2014 NZ$1.68 M-39.59%
2013 NZ$2.79 M